We are live on
!
Find out more
BCPEM
Bain Capital Public Equity Management Portfolio holdings
AUM
$1.05B
1-Year Est. Return
25.71%
This Fund
S&P 500
This Quarter
Est. Return
+9.14%
1 Year Est. Return
+25.71%
3 Year Est. Return
+127.65%
5 Year Est. Return
+213.44%
10 Year Est. Return
–
AUM
$1.42B
AUM Growth
-$66.6M
(-4.5%)
Cap. Flow
-$162M
Cap. Flow
% of AUM
-11.45%
Top 10 Holdings %
Top 10 Hldgs %
61.63%
Holding
89
New
26
Increased
10
Reduced
24
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$82.2M |
| 2 |
FDC
First Data Corporation
FDC
|
+$67.3M |
| 3 |
Novartis
NVS
|
+$29.4M |
| 4 |
AABA
Altaba Inc
AABA
|
+$28.2M |
| 5 |
Lennox International
LII
|
+$22.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DOCU
DocuSign
DOCU
|
+$57.8M |
| 2 |
Gartner
IT
|
+$44M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$41M |
| 4 |
SLB Ltd
SLB
|
+$36.3M |
| 5 |
Meta Platforms (Facebook)
META
|
+$33.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.23% |
| 2 | Industrials | 25.82% |
| 3 | Consumer Discretionary | 14.11% |
| 4 | Healthcare | 10.79% |
| 5 | Communication Services | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTCH
26
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $13.6M | 0.96% |
+500,000
| New | +$14.2M |
|
27
Coca-Cola Europacific Partners
CCEP
$47.9B
| $13M | 0.92% |
286,356
-683,248
| -70% | -$29.1M |
|
|
GBT
28
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $12.2M | 0.86% |
322,316
+180,756
| +128% | +$8.01M |
|
|
CLDR
29
DELISTED
Cloudera, Inc.
CLDR
| $12.1M | 0.86% |
686,813
-516,861
| -43% | -$7.85M |
|
30
Capital One
COF
$134B
| $11.9M | 0.84% |
124,856
-159,600
| -56% | -$15.5M |
|
31
ATI
ATI
$31B
| $11.3M | 0.8% |
382,698
-37,138
| -9% | -$999K |
|
|
GSAH.U
32
DELISTED
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
| $10.4M | 0.73% |
1,000,000
| – | – |
|
|
33
Gartner
IT
$11.7B
| $10.2M | 0.72% |
64,162
-303,334
| -83% | -$44M |
|
34
Salesforce
CRM
$158B
| $10.1M | 0.71% |
63,327
| – | – |
|
35
Sea Limited
SE
$69.5B
| $9.73M | 0.69% |
703,536
+515,334
| +274% | +$7.42M |
|
36
Hubbell
HUBB
$27.2B
| $8.67M | 0.61% |
+64,887
| New | +$7.97M |
|
37
Fortive
FTV
$18.6B
| $7.67M | 0.54% |
144,362
-325,816
| -69% | -$16.7M |
|
|
TBIO
38
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $7.38M | 0.52% |
738,543
-236,300
| -24% | -$2.75M |
|
|
39
SLB Ltd
SLB
$75B
| $6.97M | 0.49% |
114,482
-563,142
| -83% | -$36.3M |
|
40
Liberty Media Series C
FWONK
$25.8B
| $6.38M | 0.45% |
177,405
-131,686
| -43% | -$4.65M |
|
|
41
Meta Platforms (Facebook)
META
$1.51T
| $5.64M | 0.4% |
34,282
-185,840
| -84% | -$33.6M |
|
42
CALL
Crown Holdings
CCK
$13.1B
| $4.84M | 0.34% |
+22,500
| New | +$1,000K |
|
43
CALL
Hilton Worldwide
HLT
$71.5B
| $4.65M | 0.33% |
+15,000
| New | +$1.18M |
|
44
CALL
RH
RH
$3.71B
| $4M | 0.28% |
+3,753
| New | +$526K |
|
|
IMDZ
45
DELISTED
Immune Design Corp.
IMDZ
| $3.93M | 0.28% |
1,139,944
-81,424
| -7% | -$306K |
|
46
PUT
Baker Hughes
BKR
$61.1B
| $2.49M | 0.18% |
+23,200
| New | +$767K |
|
47
PUT
Invesco QQQ Trust
QQQ
$481B
| $2.32M | 0.16% |
8,636
-1,686
| -16% | -$305K |
|
48
CALL
Wynn Resorts
WYNN
$10.6B
| $1.98M | 0.14% |
+3,640
| New | +$540K |
|
|
49
CALL
Meta Platforms (Facebook)
META
$1.51T
| $1.52M | 0.11% |
+2,550
| New | +$462K |
|
50
PUT
GE Aerospace
GE
$384B
| $1.46M | 0.1% |
8,346
-9,390
| -53% | -$579K |
|
Similar funds
WF
DCM
AB
MFBTD
IAS
SA
TL
ACM
Bain Capital Public Equity Management's Q3 2018 Portfolio in Review
As of Q3 2018, Bain Capital Public Equity Management held 89 positions worth $1.42B, down 4.5% from $1.48B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Bain Capital Public Equity Management withdrew a net $162M in Q3 2018, closing 25 positions and reducing 24 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 42% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Bain Capital Public Equity Management opened a new position in Caterpillar worth $88.6M.
- Bain Capital Public Equity Management's largest Q3 2018 buy was Caterpillar: 581,215 shares worth $88.6M.
- Bain Capital Public Equity Management added most to Novartis in Q3 2018, an estimated $29.4M increase.
- Bain Capital Public Equity Management's biggest Q3 2018 reduction was DocuSign, cutting an estimated $57.8M.
- Bain Capital Public Equity Management fully exited Vertex Pharmaceuticals in Q3 2018, selling an estimated $41M.
- Bain Capital Public Equity Management's ten largest holdings make up 62% of its $1.42B portfolio in Q3 2018.
- Bain Capital Public Equity Management opened 26 new positions and closed 25 in Q3 2018.
- Bain Capital Public Equity Management's portfolio value fell 4.5% quarter-over-quarter to $1.42B.
Based on Bain Capital Public Equity Management's 13F filing for Q3 2018, filed 14 Nov 2018.